CLINICAL INK, INC.

Profile

Company Names

CLINICAL INK, INC.

Addresses

525 VINE STREET, SUITE 130, WINSTON-SALEM, NC 27101

525 VINE STREET, SUITE 130, WINSTON-SALEM, NC 27101

100 N. CHERRY STREET, STE 520, WINSTON-SALEM, NC 27101

100 NORTH CHERRY STREET, STE 520, WINSTON-SALEM, NC 27101

6101 SEWARD ROAD, PFAFFTOWN, NC 27040

Phone Numbers

336-464-0702
336-714-7402
336-714-7402 X801

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2006

State Incorporated:

NORTH CAROLINA

Total Amount Raised:

$21,706,236.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2018-05-09 
$5,314,013.00 
INDEFINITE 
INDEFINITE 
Equity 
5
2017-12-13 
$1,700,000.00 
$2,500,000.00 
$800,000.00 
Debt 
4
2015-03-19 
$9,860,223.00 
$9,860,223.00 
$0.00 
Equity 
3
2013-10-15 
$1,300,000.00 
$4,300,000.00 
$3,000,000.00 
Equity 
2
2011-11-28 
$3,132,000.00 
$3,500,000.00 
$368,000.00 
Equity 
1
2010-07-01 
$400,000.00 
$1,000,000.00 
$600,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
H. 
COLTRIN 
DIRECTOR
CLINICAL INK, INC.
ROGER 
LAVERN 
DAVENPORT 
DIRECTOR
CLINICAL INK, INC.
TODD 
 
FOLEY 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  ZALICUS INC.   |  CELLADON CORP   |  SELEXYS PHARMACEUTICALS CORP   |  PROTEON THERAPEUTICS INC   |  ICONIC THERAPEUTICS INC   |  VALERITAS INC   |  TETHEREX PHARMACEUTICALS CORP   |  CLINICAL INK, INC.   |  SEMMA THERAPEUTICS, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  MOAT BIOTECHNOLOGY CORP   |  CROSSBOW THERAPEUTICS, INC.   |  FIREFLY BIO, INC.   |  AKTIS ONCOLOGY, INC.
ANSBERT 
 
GADICKE 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  CERIMON PHARMACEUTICALS, INC.   |  MPM BIOVENTURES V, L.P.   |  VERASTEM, INC.   |  ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC   |  MITOKYNE, INC.   |  CLINICAL INK, INC.   |  VIRACYTE, INC.   |  ALLOVIR, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  ITEOS THERAPEUTICS, INC.   |  ONCOLOGY IMPACT FUND 2, L.P.   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  NEXTPOINT THERAPEUTICS, INC.   |  MPM BIOVENTURES 2022, L.P.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
BRAD 
 
GEESAMAN 
DIRECTOR
CLINICAL INK, INC.
MORANA 
 
JOVAN-EMBIRICOS 
DIRECTOR
CLINICAL INK, INC.   |  ALLOVIR, INC.   |  CULLINAN MICA CORP.   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  F2 CAPITAL I 2023 LLC
MATT 
 
KING 
DIRECTOR
MEDICAL REIMBURSEMENTS OF AMERICA, INC.   |  EDO INTERACTIVE INC   |  CLINICAL INK, INC.   |  NOVARUS HEALTHCARE, INC.   |  CLUBUP, LLC   |  IUNU, INC.   |  HEARTWOOD BIOMASS INC.   |  T1P VANQUISH DIG EREBOR I A SERIES OF ALLOCATIONS 2025 MASTER, LLC   |  BUFFALO POWER SPV, LP
MATTHEW 
 
KING 
DIRECTOR
ND ACQUISITIONS CORP.   |  PROFITPOINT INC   |  ONFOCUS HEALTHCARE INC   |  EDO INTERACTIVE INC   |  ONFOCUS HEALTHCARE, INC.   |  STUDIONOW, INC.   |  KERAFAST, INC.   |  ONE MEDICAL PASSPORT, INC.   |  VERICRED, INC.   |  NVOLVE, INC.   |  CLINICAL INK, INC.   |  2019 FCA V-CW SPV, LLC   |  HEARTWOOD BIOMASS LLC   |  CLUBUP, LLC   |  AUTOMATED FRUIT SCOUTING INC.   |  ENABLE DENTAL INC.   |  VALHALLA VENTURES FUND I LP   |  VALHALLA VENTURES TERRAN BIO SPV II LLC   |  VALHALLA VENTURES FUND I-A LP   |  KNOXVILLE HOLDINGS 24, LLC   |  IGNITEDATA (DELAWARE) INC.
ROBERT 
 
KNIEJSKI 
DIRECTOR
CLINICAL INK, INC.
MICHAEL 
 
LESTER 
DIRECTOR
CLINICAL INK, INC.   |  BENEFIT HARBOR, LP
THOMAS 
W 
LITTLEJOHN, III 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINICAL INK, INC.
RICHARD 
 
MALCOLM 
DIRECTOR
CLINICAL INK, INC.
SCOTT 
 
MILTENBERGER 
EXECUTIVE OFFICER
CLINICAL INK, INC.
DOUGLAS 
E 
PIERCE, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINICAL INK, INC.
DOUGLAS 
E. 
PIERCE, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINICAL INK, INC.
CHRISTOPHER 
H 
RAMM 
DIRECTOR
CLINICAL INK, INC.
CHRISTOPHER 
H. 
RAMM 
DIRECTOR
CLINICAL INK, INC.
TONY 
 
ROSENBERG 
DIRECTOR
CLINICAL INK, INC.
JOE 
 
SCHMIDT 
EXECUTIVE OFFICER
CLINICAL INK, INC.
EDWARD 
S. 
SEGUINE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINICAL INK, INC.
EDWARD 
S 
SEGUINE, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINICAL INK, INC.
EDWARD 
S. 
SEGUINE, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINICAL INK, INC.   |  ORI, INC. / UT
MICHAEL 
 
SORENSEN 
DIRECTOR
CLINICAL INK, INC.   |  NQ PE PROJECT CONSTELLATION, L.P.   |  WILD ENERGY, INC.   |  PRO-FICIENCY HOLDINGS, INC.   |  NQ PE PROJECT DURM PARENT, L.P.   |  NQ PE PROJECT COLOSSEUM PARENT, L.P.   |  INDESIGN LLC   |  QHP PRIVATE EQUITY FUND III-A, L.P.   |  QHP PRIVATE EQUITY FUND III-B, L.P.
PHIL 
 
WAUGH 
DIRECTOR
CLINICAL INK, INC.
PHILIP 
RS 
WAUGH, JR. 
DIRECTOR
CLINICAL INK, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-05-18
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-09 
2017-12-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2017-12-13 
2015-04-07
D/A
Link
OTHER 
 
$5,000,001 - $25,000,000 
Equity 
2015-03-19 
2015-04-02
D
Link
OTHER 
 
$1,000,001 - $5,000,000 
Equity 
2015-03-19 
2013-10-29
D
Link
OTHER 
 
$1,000,001 - $5,000,000 
Equity 
2013-10-15 
2011-12-08
D
Link
OTHER 
 
NO REVENUES 
Equity 
2011-11-28 
2010-07-14
D
Link
OTHER 
 
NO REVENUES 
Equity 
2010-07-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#